MIP Diagnostics Ltd. has announced that its synthetic SARS-CoV-2 antibody can detect the Omicron variant as well as previously proven Alpha, Beta, Delta and Gamma variants of the COVID-19 virus.

AMSBIO has announced new additions to its portfolio of tools for COVID-19 research - two monoclonal antibodies that recognize the Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2.

Avacta Group plc, a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics, provides an update on the performance of the AffiDX® SARS-CoV-2 antigen lateral flow test (LFT) with the Omicron variant.

Ziath reports how its super-fast 2D barcode rack readers are assisting COVID-19 testing lab – SummerBio LLC to offer rapid, low-cost, high-volume testing solutions for educational organizations, employers and laboratories.

Evotec SE has announced that the Company has been selected by the German Federal Ministry of Education and Research to receive a grant for the development of a potential first-in-class immunomodulatory therapy against COVID 19.

Ziath reports how its super-fast 2D barcode rack readers are assisting a leading COVID-19 testing lab to offer rapid, low-cost, high-volume testing solutions for educational organizations, employers and laboratories.